Clinical trial
Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and…
NCT00399451 · Liaoyang Central Hospital, Other · Unknown status
Key facts
| NCT number | NCT00399451 |
|---|---|
| Title | Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS) |
| Official title | Preliminary Study on Submucous Sclerosis of Pharynges With 1% Polidocanol to Treat Obstructive Sleep Apnea (OSA) & Snoring Subjects (SS) |
| Lead sponsor | Liaoyang Central Hospital, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Apnea, Snoring |
| Intervention type | Drug |
| Interventions | Polidocanol Sclerotherapy |
| Enrollment | 30 |
| Start date | Dec 1, 2006 |
| Completion | Jun 1, 2009 |
| First posted | Nov 14, 2006 |
| Last update posted | Nov 22, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: